Comparison of the Sugarbaker and Keyhole Repair for Parastomal Hernia
Launched by FUDAN UNIVERSITY · Oct 8, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical methods for repairing a condition called parastomal hernia (PSH). PSH happens when tissue pushes through the abdominal wall near a stoma, an opening created for waste to leave the body. The two methods being compared are called the Sugarbaker technique and the Keyhole repair. Researchers want to find out which method is safer and more effective, especially in patients from East Asia. They will look back at patients who had these surgeries between August 2012 and August 2022 to see how many experienced a recurrence of the hernia within a year after their surgery.
To be eligible for this study, patients must have been diagnosed with PSH and received either the Sugarbaker or Keyhole repair methods. However, those who had other types of hernia repairs or did not have a follow-up period of at least one year will not be included. This study is not yet recruiting participants, but it aims to provide important information about the best surgical options for treating parastomal hernias, which can help improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Only PSH patients who received intraperitoneal onlay Sugarbaker and Keyhole mesh were included.
- Exclusion Criteria:
- • Patients with less than one year follow-up periods were excluded from the cohort.
- • Patients received other repair approaches.
About Fudan University
Fudan University, a prestigious comprehensive research university located in Shanghai, China, is committed to advancing medical science through innovative clinical research. Renowned for its rigorous academic standards and cutting-edge research facilities, Fudan University plays a pivotal role in the global health landscape by sponsoring a diverse array of clinical trials aimed at improving patient outcomes and addressing pressing medical challenges. Leveraging its multidisciplinary expertise and collaborative networks, the university strives to translate scientific discoveries into practical applications, fostering advancements in healthcare and contributing to the well-being of communities both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported